Literature DB >> 22302091

Correction of an important typographical error in the European Association of Nuclear Medicine (EANM) guidelines.

E A Anderson.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22302091     DOI： 10.1007/s00259-012-2066-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  2 in total

1.  High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.

Authors:  Hanneke M van Santen; Jan de Kraker; Berthe L F van Eck; Jan J M de Vijlder; Thomas Vulsma
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

2.  EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.

Authors:  Francesco Giammarile; Arturo Chiti; Michael Lassmann; Boudewijn Brans; Glenn Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.